https://www.selleckchem.com/pr....oducts/chlorin-e6.ht
Regular monitoring of psoriatic patients is recommended during long-term treatment with biological drugs in order to identify cases of re-activation of the latent infective agent or acquired infection. Here we report the state of art regarding management of psoriatic patients with these co-morbidities suggesting a specific screening and management for infectious diseases in patients with moderate to severe plaque psoriasis. Here we report the state of art regarding management of psoriatic patients with these co-morbidities suggesting